Elobixibat for Chronic Constipation Without Defecation Desire
Status:
Not yet recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Patients of chronic constipation without defecation desire will be orally administered
elobixibat 10 mg once daily before meals for 4 weeks. The primary endpoint of the pre/post
comparative study will be the percentage of improvement in bowel movements from Week 2 of the
observation period at Week 4 of the treatment period.